Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Primary Peritoneal Carcinoma
Related studies linked through entity extraction aliases.
A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Ramucirumab in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy
- Status
- WITHDRAWN
- Phase
- NA
Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
- Status
- RECRUITING
- Phase
- N/A
Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
- Status
- COMPLETED
- Phase
- PHASE2